Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Orlistat (Xenical).

A M MacConnachie

    Intensive & Critical Care Nursing
    |May 16, 2000
    PubMed
    Summary

    Orlistat, a weight-loss medication, is not a quick fix but may help individuals with serious obesity. It offers a potential treatment option for managing severe weight-related health conditions.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Zanamivir (Relenza )--a new treatment for influenza.

    Intensive & critical care nursing·2002
    Same author

    Palivizumab (Synagis) for prevention of respiratory illness in children.

    Intensive & critical care nursing·2002
    Same author

    Bupropion (Zyban) for smoking cessation.

    Intensive & critical care nursing·2000
    Same author

    Rofecoxib (Vioxx)--the first of a new generation of NSAIDs.

    Intensive & critical care nursing·2000
    Same author

    Temozolomide (Temodal) for treatment of primary brain tumours.

    Intensive & critical care nursing·2000
    Same author

    New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin.

    Intensive & critical care nursing·2000

    Area of Science:

    • Pharmacology
    • Obesity Medicine
    • Gastroenterology

    Background:

    • Orlistat recently launched with significant media attention, often misrepresented as an easy weight-loss solution.
    • Public perception of orlistat as a 'quick fix' for weight loss is inaccurate.
    • Obesity presents serious, potentially life-threatening health risks.

    Purpose of the Study:

    • To evaluate the role of orlistat in managing obesity.
    • To provide an accurate perspective on orlistat's efficacy beyond simplistic 'diet-free' claims.

    Main Methods:

    • Clinical evaluation of orlistat's impact on weight management.
    • Assessment of orlistat's utility in patients with severe obesity.

    Main Results:

    • Orlistat's effectiveness is nuanced and not a simple solution for weight loss.
    • Treatment with orlistat demonstrates potential utility in specific patient populations.

    Conclusions:

    • Orlistat is not a 'quick fix' for weight loss.
    • Orlistat may serve as a valuable therapeutic option for individuals with severe or life-threatening obesity.